These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6740300)

  • 21. Interrelationship between thyroid nodularity and TSH level.
    Sachmechi I; Vahedi M; Nalamasu S; Vuppalanchi R
    Mt Sinai J Med; 2005 Jan; 72(1):33-5. PubMed ID: 15682260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term study of serum calcium changes following goitre resection.
    Aagaard J; Blichert-Toft M; Christiansen C
    Ann Chir Gynaecol; 1984; 73(2):73-7. PubMed ID: 6465822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Behavior of TBII (TSH receptor binding immunoglobulins) in multinodular struma].
    Sussi PL; Burro A; Dagradi V; Abrescia F; Patuzzo E; Degara A
    Chir Ital; 1987 Dec; 39(6):527-32. PubMed ID: 2895687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxic multinodular goiter in the elderly.
    Vitti P; Rago T; Tonacchera M; Pinchera A
    J Endocrinol Invest; 2002; 25(10 Suppl):16-8. PubMed ID: 12508907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patients.
    Duren M; Siperstein AE; Shen W; Duh QY; Morita E; Clark OH
    Surgery; 1999 Jul; 126(1):13-9. PubMed ID: 10418587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppressive therapy with levothyroxine for euthyroid diffuse and nodular goiter.
    Güllü S; Gürses MA; Başkal N; Uysal AR; Kamel AN; Erdoğan G
    Endocr J; 1999 Feb; 46(1):221-6. PubMed ID: 10426591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for autonomous thyroglobulin release from euthyroid and hyperthyroid nodular goiter--thyroglobulin, a possible helpful parameter in diagnosis of non-malignant thyroid disorders.
    Gärtner R; Hainzinger A; Horn K; Pickardt RC
    Klin Wochenschr; 1983 Aug; 61(15):737-41. PubMed ID: 6413750
    [No Abstract]   [Full Text] [Related]  

  • 30. Total versus subtotal thyroidectomy for the management of benign multinodular goiter in an endemic region.
    Colak T; Akca T; Kanik A; Yapici D; Aydin S
    ANZ J Surg; 2004 Nov; 74(11):974-8. PubMed ID: 15550086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical value of a sensitive TSH-RIA].
    Seidel C; Ziegelitz D; Weber A; Dittmer T; Gerl H; Knappe G; Correns HJ
    Endokrinologie; 1982 Oct; 80(2):181-93. PubMed ID: 6819129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical therapeutic planning options in nodular goiter.
    Pelizzo MR; Merante Boschin I; Toniato A; Sorgato N; Marzola MC; Rubello D
    Minerva Endocrinol; 2010 Sep; 35(3):173-85. PubMed ID: 20938420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LigaSure vs clamp-and-tie technique to achieve hemostasis in total thyroidectomy for benign multinodular goiter: a prospective randomized study.
    Saint Marc O; Cogliandolo A; Piquard A; Famà F; Pidoto RR
    Arch Surg; 2007 Feb; 142(2):150-6; discussion 157. PubMed ID: 17309966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nontoxic multinodular goiter: evaluation of recurrence rate and function after partial thyroidectomy. Retrospective analysis of 39 cases].
    Botelho Lde S; Rosenthal D; Machado Filho A; Figueiredo JG
    Rev Assoc Med Bras (1992); 1992; 38(2):85-9. PubMed ID: 1307072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thyroxine in an amount of 150 micrograms daily for the prevention of the recurrence of goiter].
    Goebel R; Leb G; Warnkross H; Köle W
    Acta Med Austriaca; 1977; 4(5):203-6. PubMed ID: 613702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine following partial thyroidectomy for nontoxic nodular goiter.
    Shigemasa C; Adachi T; Igawa O; Taniguchi S; Mitani Y; Ueta Y; Hori S; Yoshida A; Yamauchi N; Mashiba H
    Metabolism; 1988 Jul; 37(7):677-82. PubMed ID: 3386534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nodular goiter: thyroglobulin as an indicator for the tendency to recur?].
    Wagner HE; Ballmer FT; Teuscher J
    Helv Chir Acta; 1987 Dec; 54(4):361-3. PubMed ID: 3446622
    [No Abstract]   [Full Text] [Related]  

  • 38. [Biological markers reflecting peripheral effects of thyroid hormones in autonomous thyroid adenoma].
    Földes J; Németh J; Bános C; Tarján G; Büki B
    Orv Hetil; 1991 Sep; 132(36):1983-5. PubMed ID: 1923470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The advantage of total thyroidectomy to avoid reoperation for incidental thyroid cancer in multinodular goiter.
    Giles Y; Boztepe H; Terzioglu T; Tezelman S
    Arch Surg; 2004 Feb; 139(2):179-82. PubMed ID: 14769577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Is primary total thyroidectomy justified in benign multinodular goiter? Results of a prospective quality assurance study of 45 hospitals offering different levels of care].
    Thomusch O; Sekulla C; Dralle H
    Chirurg; 2003 May; 74(5):437-43. PubMed ID: 12748792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.